Literature DB >> 9026031

Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats.

H Sakai1, S Takeoka, S I Park, T Kose, H Nishide, Y Izumi, A Yoshizu, K Kobayashi, E Tsuchida.   

Abstract

Poly(ethylene glycol) (PEG5000)-conjugated phosphatidylethanolamine was introduced onto the surface of hemoglobin vesicles (HbV); phospholipid vesicles encapsulating concentrated Hb (d = 0.257 +/- 0.087 micron; P50 = 32 Torr). The obtained PEG-modified HbV (HbV-PEG) was studied for use as a red cell substitute from the viewpoint of rheology, surface properties, and hemodynamics. The viscosity of the unmodified HbV suspended in saline ([Hb] = 10 g/dL) was 2.6 cP (shear rate = 358 s-1, 37 degrees C), less than that of human blood (4 cP). However, when suspended in a 5 g/dL albumin solution (HbV/ albumin), it increased to 8 cP due to the molecular interaction between albumin and vesicles, and the viscosity increased with decreasing shear rate, e.g., 37 cP at 0.58 s-1. As for the HbV-PEG/albumin, on the other hand, the viscosity was 3.5 cP at 358 s-1 and was comparable with that of human blood. Optical microscopy showed formless flocculated aggregates of the unmodified HbV, while no aggregates were confirmed for the HbV-PEG. The steric hindrance of PEG chains seemed to be effective in preventing intervesicular access and the resulting aggregation. To estimate the flow profiles in the capillaries, the suspensions were allowed to penetrate through isopore membrane filters (pore size = 0.4-8 microns, cf. capillary diameter = 4-10 microns). The penetration rate of the HbV-PEG/albumin was higher than that of the unmodified HbV/albumin due to the suppression of aggregation, whereas both of them were significantly higher than that of human blood due to the smaller size of vesicles than RBC. Ninety percent exchange transfusion was performed with the HbV-PEG/albumin or HbV/albumin in anesthetized Wistar rats (n = 6). The blood flow in the abdominal aorta increased 1.5 times, and the total peripheral resistance decreased in the HbV-PEG/albumin-administered group in comparison with the HbV/albumin group. As for the blood gas parameters, the base excess and pH remained at higher levels in the HbV-PEG/albumin group, and the O2 tension in mixed venous blood for the HbV-PEG/albumin group tended to be maintained at a higher level than that for the HbV/albumin group. Thus, the PEG modification of HbV reduced the viscosity by the suppression of aggregation and resulted in prompt blood circulation in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9026031     DOI: 10.1021/bc960069p

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  14 in total

1.  Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.

Authors:  H Sakai; H Horinouchi; K Tomiyama; E Ikeda; S Takeoka; K Kobayashi; E Tsuchida
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  The impact on renal function of fluid resuscitation with hemoglobin vesicle solution in moderate hemorrhagic shock.

Authors:  Yuka Saito; Yasutomo Suzuki; Yoshitaka Yamanashi; Katsuyuki Terajima; Atsuhiro Sakamoto; Yukihiro Kondo
Journal:  J Artif Organs       Date:  2013-05-21       Impact factor: 1.731

3.  Simple method for preparing poly(ethylene glycol)-surface-conjugated liposome-encapsulated hemoglobins: physicochemical properties, long-term storage stability, and their reactions with O2, CO, and NO.

Authors:  Shahid Rameez; Andre F Palmer
Journal:  Langmuir       Date:  2011-06-16       Impact factor: 3.882

4.  Functional analysis of recombinant human serum albumin domains for pharmaceutical applications.

Authors:  Sadaharu Matsushita; Yu Isima; Victor Tuan Giam Chuang; Hiroshi Watanabe; Sumio Tanase; Tomu Maruyama; Masaki Otagiri
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

5.  Scalable production and complete biophysical characterization of poly(ethylene glycol) surface conjugated liposome encapsulated hemoglobin (PEG-LEH).

Authors:  Uddyalok Banerjee; Savannah Wolfe; Quintin O'Boyle; Clayton Cuddington; Andre F Palmer
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

6.  Long-Term Stored Hemoglobin-Vesicles, a Cellular Type of Hemoglobin-Based Oxygen Carrier, Has Resuscitative Effects Comparable to That for Fresh Red Blood Cells in a Rat Model with Massive Hemorrhage without Post-Transfusion Lung Injury.

Authors:  Masahiro Tokuno; Kazuaki Taguchi; Keishi Yamasaki; Hiromi Sakai; Masaki Otagiri
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

Review 7.  Biocompatibility of HbV: Liposome-Encapsulated Hemoglobin Molecules-Liposome Effects on Immune Function.

Authors:  Hiroshi Azuma; Mitsuhiro Fujihara; Hiromi Sakai
Journal:  J Funct Biomater       Date:  2017-06-28

Review 8.  Overview of Potential Clinical Applications of Hemoglobin Vesicles (HbV) as Artificial Red Cells, Evidenced by Preclinical Studies of the Academic Research Consortium.

Authors:  Hiromi Sakai
Journal:  J Funct Biomater       Date:  2017-03-15

9.  Albumin-derived perfluorocarbon-based artificial oxygen carriers can avoid hypoxic tissue damage in massive hemodilution.

Authors:  Anna Wrobeln; Johannes Jägers; Theresa Quinting; Timm Schreiber; Michael Kirsch; Joachim Fandrey; Katja B Ferenz
Journal:  Sci Rep       Date:  2020-07-20       Impact factor: 4.379

10.  Carbon monoxide-bound hemoglobin vesicles ameliorate multiorgan injuries induced by severe acute pancreatitis in mice by their anti-inflammatory and antioxidant properties.

Authors:  Saori Nagao; Kazuaki Taguchi; Hiromi Sakai; Keishi Yamasaki; Hiroshi Watanabe; Masaki Otagiri; Toru Maruyama
Journal:  Int J Nanomedicine       Date:  2016-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.